Affordable Access

deepdyve-link
Publisher Website

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.

Authors
  • Dimeglio, Chloé1
  • Loubes, Jean-Michel2
  • Deporte, Benjamin2
  • Dubois, Martine3
  • Latour, Justine4
  • Mansuy, Jean-Michel4
  • Izopet, Jacques3
  • 1 UMR Inserm, U1043; UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse 31300, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France. Electronic address: [email protected] , (France)
  • 2 Université de Toulouse, Institut de Mathématiques de Toulouse, Toulouse 31400, France. , (France)
  • 3 UMR Inserm, U1043; UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse 31300, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France. , (France)
  • 4 CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France. , (France)
Type
Published Article
Journal
The Journal of infection
Publication Date
Apr 29, 2020
Identifiers
DOI: 10.1016/j.jinf.2020.04.031
PMID: 32360497
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy. Copyright © 2020 Elsevier Ltd. All rights reserved.

Report this publication

Statistics

Seen <100 times